Article
PD-L1 expression with immune-infiltrate evaluation and outcome prediction in melanoma patients treated with ipilimumab.
Oncoimmunology
Document Type
Article
Publication Date
1-1-2018
Keywords
- Immunotherapy,
- Ipilimumab,
- Melanoma,
- PD-L1,
- Tumor microenvironment,
- genomics
Disciplines
Clinical Institute
Cancer
Specialty
Earle A. Chiles Research Institute
Specialty
Oncology
Citation Information
Gabriele Madonna, Carmen Ballesteros-Merino, Zipei Feng, Carlo Bifulco, et al.. "PD-L1 expression with immune-infiltrate evaluation and outcome prediction in melanoma patients treated with ipilimumab." Oncoimmunology (2018) Available at: http://works.bepress.com/carlo-bifulco/29/